Stocks · Health care · Pharmaceutical Preparations

Werewolf Therapeutics, Inc.

HOWL Clue Score19
United States Fiscal year ends December CIK 0001785530 Results filed 31 Jul 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Ra Capital Management, L.p.
17 Jun 2026
10% owner
Sell indirect
27,695
$0.35
$9.69K
Ra Capital Management, L.p.
17 Jun 2026
10% owner
Sell indirect
389,216
$0.35
$136.23K
Ra Capital Management, L.p.
16 Jun 2026
10% owner
Sell indirect
9,939
$0.37
$3.68K
Ra Capital Management, L.p.
16 Jun 2026
10% owner
Sell indirect
139,686
$0.37
$51.68K
Ra Capital Management, L.p.
15 Jun 2026
10% owner
Sell indirect
8,554
$0.39
$3.34K
Ra Capital Management, L.p.
15 Jun 2026
10% owner
Sell indirect
120,216
$0.39
$46.88K
Ra Capital Management, L.p.
12 Jun 2026
10% owner
Sell indirect
11,322
$0.40
$4.53K
Ra Capital Management, L.p.
12 Jun 2026
10% owner
Sell indirect
159,119
$0.40
$63.65K
Ra Capital Management, L.p.
11 Jun 2026
10% owner
Sell indirect
17,437
$0.38
$6.63K
Ra Capital Management, L.p.
11 Jun 2026
10% owner
Sell indirect
245,066
$0.38
$93.13K
Ra Capital Management, L.p.
10 Jun 2026
10% owner
Sell indirect
3,051
$0.37
$1.13K
Ra Capital Management, L.p.
10 Jun 2026
10% owner
Sell indirect
42,872
$0.37
$15.86K
Ra Capital Management, L.p.
9 Jun 2026
10% owner
Sell indirect
24,565
$0.37
$9.09K
Ra Capital Management, L.p.
9 Jun 2026
10% owner
Sell indirect
345,235
$0.37
$127.74K
Ra Capital Management, L.p.
12 May 2026
10% owner
Sell indirect
6,719
$0.64
$4.30K
Ra Capital Management, L.p.
12 May 2026
10% owner
Sell indirect
94,432
$0.64
$60.44K
Ra Capital Management, L.p.
11 May 2026
10% owner
Sell indirect
5,812
$0.67
$3.89K
Ra Capital Management, L.p.
11 May 2026
10% owner
Sell indirect
81,678
$0.67
$54.72K
Ra Capital Management, L.p.
8 May 2026
10% owner
Sell indirect
25,012
$0.71
$17.76K
Ra Capital Management, L.p.
8 May 2026
10% owner
Sell indirect
351,514
$0.71
$249.57K

What was left out

Form 4 filings counted 47
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 18
Sales on a Rule 10b5-1 plan 119
Sales straight out of an exercise 0
Sales at will 20
Transactions with no price 0
Shares from compensation/vesting 0
History held since 3 May 2021